An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG)

Authors

  • Anne-Vibeke Laenkholm Department of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark
  • Dorthe Grabau Department of Pathology, Skåne University Hospital, Lund, Sweden
  • Maj-Lis Møller Talman Department of Pathology, Rigshospitalet, Copenhagen, Denmark
  • Eva Balslev Department of Pathology, Herlev Hospital, Herlev, Denmark
  • Anne Marie Bak Jylling Department of Pathology, Odense University Hospital, Odense, Denmark
  • Tomasz Piotr Tabor Department of Pathology, Lillebaelt Hospital, Vejle, Denmark
  • Morten Johansen Department of Pathology, North Denmark Regional Hospital, Hjørring, Denmark
  • Anja Brügmann Department of Pathology, Aalborg University Hospital, Aalborg, Denmark
  • Giedrius Lelkaitis Department of Pathology, Rigshospitalet, Copenhagen, Denmark
  • Tina Di Caterino Department of Pathology, Hospital of South West Jutland, Esbjerg, Denmark
  • Henrik Mygind Department of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark
  • Thomas Poulsen Department of Pathology, Sygehus Soenderjylland, Sønderborg, Denmark
  • Henrik Mertz Department of Pathology, Regional Hospital of Randers, Randers, Denmark
  • Gorm Søndergaard Department of Pathology, Region Hospital of Viborg, Viborg, Denmark
  • Birgitte Bruun Rasmussen Department of Pathology, Herlev Hospital, Herlev, Denmark

DOI:

https://doi.org/10.1080/0284186X.2017.1404127

Abstract

Introduction: In 2011, the St. Gallen Consensus Conference introduced the use of pathology to define the intrinsic breast cancer subtypes by application of immunohistochemical (IHC) surrogate markers ER, PR, HER2 and Ki67 with a specified Ki67 cutoff (>14%) for luminal B-like definition. Reports concerning impaired reproducibility of Ki67 estimation and threshold inconsistency led to the initiation of this quality assurance study (2013–2015). The aim of the study was to investigate inter-observer variation for Ki67 estimation in malignant breast tumors by two different quantification methods (assessment method and count method) including measure of agreement between methods.

Material and methods: Fourteen experienced breast pathologists from 12 pathology departments evaluated 118 slides from a consecutive series of malignant breast tumors. The staining interpretation was performed according to both the Danish and Swedish guidelines. Reproducibility was quantified by intra-class correlation coefficient (ICC) and Lights Kappa with dichotomization of observations at the larger than (>) 20% threshold. The agreement between observations by the two quantification methods was evaluated by Bland–Altman plot.

Results: For the fourteen raters the median ranged from 20% to 40% by the assessment method and from 22.5% to 36.5% by the count method. Light’s Kappa was 0.664 for observation by the assessment method and 0.649 by the count method. The ICC was 0.82 (95% CI: 0.77–0.86) by the assessment method vs. 0.84 (95% CI: 0.80–0.87) by the count method.

Conclusion: Although the study in general showed a moderate to good inter-observer agreement according to both ICC and Lights Kappa, still major discrepancies were identified in especially the mid-range of observations. Consequently, for now Ki67 estimation is not implemented in the DBCG treatment algorithm.

Downloads

Download data is not yet available.

Downloads

Published

2018-01-02

How to Cite

Laenkholm, A.-V., Grabau, D., Møller Talman, M.-L., Balslev, E., Marie Bak Jylling, A., Piotr Tabor, T., … Bruun Rasmussen, B. (2018). An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG). Acta Oncologica, 57(1), 83–89. https://doi.org/10.1080/0284186X.2017.1404127